No Link Found Between Genetic Risk Factors And 2 Top Wet AMD Treatments

New findings from a landmark clinical trial show that although certain gene variants may predict whether a person is likely to develop age-related macular degeneration (AMD), a potentially blinding eye disease that afflicts more than nine million Americans, these genes do not predict how patients will respond to Lucentis™ and Avastin™, the two medications most widely used to treat the “wet” form of AMD… (Source: Health News from Medical News Today)